Inactive Instrument

All News AgeX Therapeutics, Inc.

Equities

AGE

US00848H2076

All News

Unlock all the news: Be the first to know and act before the market!

Serina Therapeutics, Inc. completed the acquisition of AgeX Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.	Mar. 25	CI
AgeX Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results	Mar. 22	AQ
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE	Feb. 27	BU
AgeX Therapeutics, Inc. Appoints Steven Mintz as a Director, Member of Audit Committee, Compensation Committee and Nominating & Corporate Governance Committee	Jan. 11	CI
AgeX Therapeutics : New Financial Obligation - Form 8-K	Dec. 28	PU
AgeX Therapeutics : Termination of Material Agreement - Form 8-K	Dec. 01	PU
Agex Therapeutics, Inc. Terminates Nafees Malik as Chief Operating Officer, Effective on December 27, 2023	Dec. 01	CI
Pfizer Signs License Agreement With Serina Therapeutics to Gain Access to POZ Polymer Technology	Nov. 17	MT
Earnings Flash (AGE) AGEX THERAPEUTICS Posts Q3 Revenue $67,000	Nov. 14	MT
AgeX Therapeutics Reports Third Quarter 2023 Financial Results	Nov. 14	BU
AgeX Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
AgeX Therapeutics : New Financial Obligation - Form 8-K	23-10-06	PU
AgeX Therapeutics, Inc. Announces Departure of Dr. Michael H. May as Director of the Company	23-09-08	CI
AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE	23-09-05	BU
AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders	23-08-30	BU
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement	23-08-30	BU
Serina Therapeutics, Inc. entered into a merger agreement to acquire AgeX Therapeutics, Inc. from shareholders in a reverse merger transaction.	23-08-29	CI
AgeX Therapeutics : New Financial Obligation - Form 8-K	23-08-25	PU
Earnings Flash (AGE) AGEX THERAPEUTICS Posts Q2 Revenue $9,000	23-08-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AgeX Therapeutics, Inc.

Equities

AGE

US00848H2076

All News

Filters